Funding Partners Duchenne UK is actively funding and accelerating therapies for Duchenne muscular dystrophy with at least one recent £500k award and ongoing collaborations, signaling strong interest in scalable translational projects that could benefit from strategic sponsorships, grants, or co-funding opportunities.

Strategic Alliances Recent and ongoing partnerships with public, private, and patient advocacy groups (Fox Payne Associates, SMA UK, PPMD) indicate a receptiveness to collaboration; sales teams can explore sponsorship packages, joint advocacy campaigns, and technology or data-sharing partnerships.

Digital Engagement A multi-technology stack and a launched app focused on caregiver and clinical guidance show an openness to digital solutions; propose fundraising platforms, CRM enhancements, donor stewardship tools, and mobile/EMR-integrated education modules.

Public Awareness High-profile media activities (podcast appearances, public campaigns, and partnerships) suggest opportunities for brand storytelling collaborations, event sponsorships, and content licensing to expand reach and donor acquisition.

Funding Scale With revenue in the low-to-mid seven figures and a clear growth trajectory, there is room for scalable programmatic funding, impact measurement services, and customized grant-management solutions to optimize allocation and reporting.